Tharimmune

Biotechnology company(THAR)

Sobre Tharimmune

Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.
Comunidade
Website
Etiquetas
Digital Asset Treasury
Publicly listed company
Crypto Stocks

Tendência da variação do índice de calor

Nenhum registo

Membros da Equipa

Mark Wendland
Mark Wendland

Chairman and CEO

Angela Radkowski
Angela Radkowski

COO

Investidores

Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest

Dados de angariação de fundos

Post-IPO(2025-11-03)
Quantia€473,36M
Investidores
Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest
Valorização--